166 related articles for article (PubMed ID: 32252259)
1. Generation of An Endogenous FGFR2-BICC1 Gene Fusion/58 Megabase Inversion Using Single-Plasmid CRISPR/Cas9 Editing in Biliary Cells.
Reicher A; Harris AL; Prinz F; Kiesslich T; Wei M; Öllinger R; Rad R; Pichler M; Kwong LN
Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32252259
[TBL] [Abstract][Full Text] [Related]
2. Functions of FGFR2 corrupted by translocations in intrahepatic cholangiocarcinoma.
Li F; Peiris MN; Donoghue DJ
Cytokine Growth Factor Rev; 2020 Apr; 52():56-67. PubMed ID: 31899106
[TBL] [Abstract][Full Text] [Related]
3. FGFR2 fusion proteins drive oncogenic transformation of mouse liver organoids towards cholangiocarcinoma.
Cristinziano G; Porru M; Lamberti D; Buglioni S; Rollo F; Amoreo CA; Manni I; Giannarelli D; Cristofoletti C; Russo G; Borad MJ; Grazi GL; Diodoro MG; Giordano S; Sacconi A; Forcato M; Anastasi S; Leonetti C; Segatto O
J Hepatol; 2021 Aug; 75(2):351-362. PubMed ID: 33741397
[TBL] [Abstract][Full Text] [Related]
4. First proficiency testing for NGS-based and combined NGS- and FISH-based detection of FGFR2 fusions in intrahepatic cholangiocarcinoma.
Neumann O; Lehmann U; Bartels S; Pfarr N; Albrecht T; Ilm K; Christmann J; Volckmar AL; Goldschmid H; Kirchner M; Allgäuer M; Walker M; Kreipe H; Tannapfel A; Weichert W; Schirmacher P; Kazdal D; Stenzinger A
J Pathol Clin Res; 2023 Mar; 9(2):100-107. PubMed ID: 36635225
[TBL] [Abstract][Full Text] [Related]
5. Efficient generation and reversion of chromosomal translocations using CRISPR/Cas technology.
Lekomtsev S; Aligianni S; Lapao A; Bürckstümmer T
BMC Genomics; 2016 Sep; 17(1):739. PubMed ID: 27640184
[TBL] [Abstract][Full Text] [Related]
6. Efficient inversions and duplications of mammalian regulatory DNA elements and gene clusters by CRISPR/Cas9.
Li J; Shou J; Guo Y; Tang Y; Wu Y; Jia Z; Zhai Y; Chen Z; Xu Q; Wu Q
J Mol Cell Biol; 2015 Aug; 7(4):284-98. PubMed ID: 25757625
[TBL] [Abstract][Full Text] [Related]
7. Gene Manipulation Using Fusion Guide RNAs for Cas9 and Cas12a.
Shin HR; Kweon J; Kim Y
Methods Mol Biol; 2021; 2162():185-193. PubMed ID: 32926383
[TBL] [Abstract][Full Text] [Related]
8. Identification and In-Depth Analysis of the Novel FGFR2-NDC80 Fusion in a Cholangiocarcinoma Patient: Implication for Therapy.
Scheiter A; Keil F; Lüke F; Grosse J; Verloh N; Opitz S; Schlosser S; Kandulski A; Pukrop T; Dietmaier W; Evert M; Calvisi DF; Utpatel K
Curr Oncol; 2021 Mar; 28(2):1161-1169. PubMed ID: 33800328
[TBL] [Abstract][Full Text] [Related]
9. CRISPR Gene Editing of Murine Blood Stem and Progenitor Cells Induces MLL-AF9 Chromosomal Translocation and MLL-AF9 Leukaemogenesis.
Sarrou E; Richmond L; Carmody RJ; Gibson B; Keeshan K
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32549410
[TBL] [Abstract][Full Text] [Related]
10. Impact of FGFR2 gene fusions on survival of patients with intrahepatic cholangiocarcinoma following curative intent resection.
Buckarma E; De La Cruz G; Truty M; Nagorney D; Cleary S; Kendrick M; Borad M; Graham RP; Gores G; Smoot R
HPB (Oxford); 2022 Oct; 24(10):1748-1756. PubMed ID: 35718679
[TBL] [Abstract][Full Text] [Related]
11. CRISPR/Cas9-Mediated Genome Editing in Epstein-Barr Virus-Transformed Lymphoblastoid B-Cell Lines.
Jiang S; Wang LW; Walsh MJ; Trudeau SJ; Gerdt C; Zhao B; Gewurz BE
Curr Protoc Mol Biol; 2018 Jan; 121():31.12.1-31.12.23. PubMed ID: 29337376
[TBL] [Abstract][Full Text] [Related]
12. Precise and Predictable CRISPR Chromosomal Rearrangements Reveal Principles of Cas9-Mediated Nucleotide Insertion.
Shou J; Li J; Liu Y; Wu Q
Mol Cell; 2018 Aug; 71(4):498-509.e4. PubMed ID: 30033371
[TBL] [Abstract][Full Text] [Related]
13. Typing FGFR2 translocation determines the response to targeted therapy of intrahepatic cholangiocarcinomas.
Pu X; Ye Q; Cai J; Yang X; Fu Y; Fan X; Wu H; Chen J; Qiu Y; Yue S
Cell Death Dis; 2021 Mar; 12(3):256. PubMed ID: 33692336
[TBL] [Abstract][Full Text] [Related]
14. CRISPR-C: circularization of genes and chromosome by CRISPR in human cells.
Møller HD; Lin L; Xiang X; Petersen TS; Huang J; Yang L; Kjeldsen E; Jensen UB; Zhang X; Liu X; Xu X; Wang J; Yang H; Church GM; Bolund L; Regenberg B; Luo Y
Nucleic Acids Res; 2018 Dec; 46(22):e131. PubMed ID: 30551175
[TBL] [Abstract][Full Text] [Related]
15. Effect of FGFR2 Alterations on Overall and Progression-Free Survival in Patients Receiving Systemic Therapy for Intrahepatic Cholangiocarcinoma.
Abou-Alfa GK; Bibeau K; Schultz N; Yaqubie A; Millang B; Ren H; Féliz L
Target Oncol; 2022 Sep; 17(5):517-527. PubMed ID: 36114955
[TBL] [Abstract][Full Text] [Related]
16. CRISPR/Cas9 Engineering of Adult Mouse Liver Demonstrates That the Dnajb1-Prkaca Gene Fusion Is Sufficient to Induce Tumors Resembling Fibrolamellar Hepatocellular Carcinoma.
Engelholm LH; Riaz A; Serra D; Dagnæs-Hansen F; Johansen JV; Santoni-Rugiu E; Hansen SH; Niola F; Frödin M
Gastroenterology; 2017 Dec; 153(6):1662-1673.e10. PubMed ID: 28923495
[TBL] [Abstract][Full Text] [Related]
17. Establishment of Cell Lines Stably Expressing dCas9-Fusions to Address Kinetics of Epigenetic Editing.
Goubert D; Koncz M; Kiss A; Rots MG
Methods Mol Biol; 2018; 1767():395-415. PubMed ID: 29524148
[TBL] [Abstract][Full Text] [Related]
18. Generation of chromosomal translocations that lead to conditional fusion protein expression using CRISPR-Cas9 and homology-directed repair.
Vanoli F; Jasin M
Methods; 2017 May; 121-122():138-145. PubMed ID: 28522325
[TBL] [Abstract][Full Text] [Related]
19. CRISPR-Cas9 genome editing induces megabase-scale chromosomal truncations.
Cullot G; Boutin J; Toutain J; Prat F; Pennamen P; Rooryck C; Teichmann M; Rousseau E; Lamrissi-Garcia I; Guyonnet-Duperat V; Bibeyran A; Lalanne M; Prouzet-Mauléon V; Turcq B; Ged C; Blouin JM; Richard E; Dabernat S; Moreau-Gaudry F; Bedel A
Nat Commun; 2019 Mar; 10(1):1136. PubMed ID: 30850590
[TBL] [Abstract][Full Text] [Related]
20. Chimeric transcripts observed in non-canonical FGFR2 fusions with partner genes' breakpoint located in intergenic region in intrahepatic cholangiocarcinoma.
Yin L; Han Z; Feng M; Wang J; Xie Z; Yu W; Fu X; Shen N; Wang X; Duan A; Zhang Y; Ma J
Cancer Genet; 2022 Aug; 266-267():39-43. PubMed ID: 35749865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
